Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Wack

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Human Immunology|August 27, 2011
Surface molecules on stimulated plasmacytoid dendritic cells are sufficient to cross-activate resting myeloid dendritic cellsRocco Cantisani, Chiara Sammicheli, Simona Tavarini, et al.
EMBO Reports|August 13, 2015
TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfectionGregory T Ellis, Sophia Davidson, Stefania Crotta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2014
Themis2 is not required for B cell development, activation, and antibody responsesHarald Hartweger, Edina Schweighoffer, Sophia Davidson, et al.
The Journal of Experimental Medicine|September 2, 2021
A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenzaJulie C F Rappe, Katja Finsterbusch, Stefania Crotta, et al.
European Journal of Immunology|March 21, 2003
T cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by LckElisabetta Soldaini, Andreas Wack, Ugo D'Oro, et al.
Nature Communications|February 13, 2023
Repair of airway epithelia requires metabolic rewiring towards fatty acid oxidationStefania Crotta, Matteo Villa, Jack Major, et al.
Faculty Reviews|July 11, 2022
Anti-type I interferon antibodies as a cause of severe COVID-19David C Fajgenbaum, Adrian C Hayday, Angela J Rogers, et al.
Journal of Innate Immunity|April 9, 2010
Intranasal administration of CpG induces a rapid and transient cytokine response followed by dendritic and natural killer cell activation and recruitment in the mouse lungIsabella Pesce, Elisabetta Monaci, Alessandro Muzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Coligation of the hepatitis C virus receptor CD81 with CD28 primes naive T lymphocytes to acquire type 2 effector functionAlessandro Serra, Sandra Nuti, Simona Tavarini, et al.
The Journal of Infectious Diseases|August 13, 2013
Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathwayPaul S Redford, Katrin D Mayer-Barber, Finlay W McNab, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Human Immunology|August 27, 2011
Surface molecules on stimulated plasmacytoid dendritic cells are sufficient to cross-activate resting myeloid dendritic cellsRocco Cantisani, Chiara Sammicheli, Simona Tavarini, et al.
EMBO Reports|August 13, 2015
TRAIL+ monocytes and monocyte-related cells cause lung damage and thereby increase susceptibility to influenza-Streptococcus pneumoniae coinfectionGregory T Ellis, Sophia Davidson, Stefania Crotta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2014
Themis2 is not required for B cell development, activation, and antibody responsesHarald Hartweger, Edina Schweighoffer, Sophia Davidson, et al.
The Journal of Experimental Medicine|September 2, 2021
A TLR7 antagonist restricts interferon-dependent and -independent immunopathology in a mouse model of severe influenzaJulie C F Rappe, Katja Finsterbusch, Stefania Crotta, et al.
European Journal of Immunology|March 21, 2003
T cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by LckElisabetta Soldaini, Andreas Wack, Ugo D'Oro, et al.
Nature Communications|February 13, 2023
Repair of airway epithelia requires metabolic rewiring towards fatty acid oxidationStefania Crotta, Matteo Villa, Jack Major, et al.
Faculty Reviews|July 11, 2022
Anti-type I interferon antibodies as a cause of severe COVID-19David C Fajgenbaum, Adrian C Hayday, Angela J Rogers, et al.
Journal of Innate Immunity|April 9, 2010
Intranasal administration of CpG induces a rapid and transient cytokine response followed by dendritic and natural killer cell activation and recruitment in the mouse lungIsabella Pesce, Elisabetta Monaci, Alessandro Muzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
Coligation of the hepatitis C virus receptor CD81 with CD28 primes naive T lymphocytes to acquire type 2 effector functionAlessandro Serra, Sandra Nuti, Simona Tavarini, et al.
The Journal of Infectious Diseases|August 13, 2013
Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathwayPaul S Redford, Katrin D Mayer-Barber, Finlay W McNab, et al.
Pageof 9